Innovate Corp (VATE) Stock Price, Quote & News

Company Profile

INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The Infrastructure segment provides industrial construction, structural steel, and facility maintenance services, such as fabrication and erection of structural steel and heavy steel plate services, and large-diameter water pipes and water storage tanks; fabrication of trusses and girders; and 3-D building information modeling and detailing for commercial, industrial, and...

Industry: Engineering & Construction

Sector: Industrials

Phone: 212 235 2691

Website: www.innovatecorp.com

Address:

295 Madison Avenue, 12th Floor, New York, United States

Foooxx Dec. 25 at 1:06 PM

$VATE Load done, ready to go up!!

0 · Reply

Foooxx Dec. 22 at 6:39 PM

$VATE

0 · Reply

IcePhoenix Dec. 17 at 4:46 PM

$VATE undervalued

0 · Reply

Rachs88 Dec. 16 at 1:17 PM

$VATE why isn't anyone talking about this?

0 · Reply

dbr_island Dec. 16 at 1:14 PM

$AMCI there it goes…… 🚨KITT🚨smart money adding here as this is heavily lagging behind its peers RR and SERV Sooner or later this will pay me HUGE I’m telling you I’m even willing to put some of my COIN TSLA profits into KITT👇💰💰💰 $VATE $RZLV $BDRX $BMNU watching

0 · Reply

Mapagotrades Dec. 16 at 1:06 PM

$VATE MediBeacon® Next Generation TGFR™ System Receives FDA Approval

0 · Reply

Stock_Catcher Dec. 16 at 1:05 PM

$VATE MediBeacon® Next Generation TGFR™ System Receives FDA Approval

0 · Reply

Black_Jobs Nov. 21 at 1:35 PM

$VATE why is there no price here?

0 · Reply

d_risk Nov. 12 at 10:04 PM

$VATE - INNOVATE Corp. Common Stock - 10Q - Updated Risk Factors VATE’s latest 10-Q expands on risks from debt covenants and restrictions tied to its notes and preferred stock, highlighting increased financial and operational constraints, but introduces no new risk categories. #FinancialConstraints #RiskManagement #PreferredStock #OperationalRisks #DebtCovenants 🟢 Added 🟠 Removed https://d-risk.ai/VATE/10-Q/2025-11-12

0 · Reply

GrindTime Nov. 6 at 3:44 PM

$VATE thats right....

0 · Reply

MediBeacon® Next Generation TGFR™ System Receives FDA Approval

Nov 12, 2025, 6:21 PM EST - 6 weeks ago

INNOVATE Corp. (VATE) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 4:04 PM EST - 6 weeks ago

INNOVATE Corp. Announces Third Quarter 2025 Results

Oct 22, 2025, 4:05 PM EDT - 2 months ago

INNOVATE Corp. to Report Third Quarter 2025 Results on November 12th

Oct 21, 2025, 8:05 AM EDT - 2 months ago

MediBeacon receives regulatory approval to sell the Transdermal GFR System in China

Oct 16, 2025, 4:15 PM EDT - 2 months ago

INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend

Sep 9, 2025, 8:39 AM EDT - 3 months ago

INNOVATE's Portfolio Company, R2, has Explosive Growth and Global Reach with Glacial® Skin Continuing to Redefine Aesthetic Innovation

Aug 5, 2025, 7:22 PM EDT - 5 months ago

INNOVATE Corp. (VATE) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:05 PM EDT - 5 months ago

INNOVATE Corp. Announces Second Quarter 2025 Results

Aug 4, 2025, 4:30 PM EDT - 5 months ago

INNOVATE Closes Indebtedness Refinancing Transactions

Jul 31, 2025, 8:30 AM EDT - 5 months ago

INNOVATE Announces Early Results of Exchange Offer of Senior Secured Notes and Solicitation of Consents and Extends Availability of Total Early Exchange Consideration

Jul 17, 2025, 4:05 PM EDT - 5 months ago

INNOVATE Corp. to Report Second Quarter 2025 Results on August 5th

Jul 17, 2025, 8:42 AM EDT - 5 months ago

INNOVATE Launches Indebtedness Refinancing Transactions

May 20, 2025, 4:06 PM EDT - 7 months ago

DBM Global Enters Into an Amended and Restated Credit Agreement

May 6, 2025, 9:02 PM EDT - 8 months ago

INNOVATE Corp. (VATE) Q1 2025 Earnings Call Transcript

May 6, 2025, 4:05 PM EDT - 8 months ago

INNOVATE Corp. Announces First Quarter 2025 Results

Apr 16, 2025, 4:05 PM EDT - 9 months ago

INNOVATE Corp. to Report First Quarter 2025 Results on May 6th

Mar 31, 2025, 10:46 PM EDT - 9 months ago

INNOVATE Corp. (VATE) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 4:04 PM EDT - 9 months ago

INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results

Feb 27, 2025, 4:02 PM EST - 10 months ago

INNOVATE Corp. to Report Fourth Quarter and Full Year 2024 Results on March 31st

Feb 25, 2025, 9:00 AM EST - 10 months ago

MediBeacon® Transdermal GFR System receives device approval in China

Jan 17, 2025, 6:18 PM EST - 1 year ago

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function

Nov 20, 2024, 8:22 AM EST - 1 year ago

INNOVATE Corp. Portfolio Company R2 Technologies Announces Another Record-Breaking Quarter and Partnerships with Woodhouse Spas and Top Skincare Brands

Nov 6, 2024, 10:19 PM EST - 1 year ago

INNOVATE Corp. (VATE) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:03 PM EST - 1 year ago

INNOVATE Corp. Announces Third Quarter 2024 Results

Oct 16, 2024, 4:05 PM EDT - 1 year ago

INNOVATE Corp. to Report Third Quarter 2024 Results on November 6th

Sep 3, 2024, 4:05 PM EDT - 1 year ago

INNOVATE Corp. Regains Compliance with NYSE Minimum Price Requirement

Aug 7, 2024, 10:09 PM EDT - 1 year ago

INNOVATE Corp. (VATE) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:04 PM EDT - 1 year ago

INNOVATE Corp. Announces Second Quarter 2024 Results

Jul 29, 2024, 8:30 AM EDT - 1 year ago

INNOVATE Corp. Announces Extension of Effective Date for Reverse Stock Split to August 8, 2024

Jul 19, 2024, 9:10 AM EDT - 1 year ago

INNOVATE Corp. Announces 1-for-10 Reverse Stock Split of the Company's Common Stock

Jul 17, 2024, 4:05 PM EDT - 1 year ago

INNOVATE Corp. to Report Second Quarter 2024 Results on August 7th

May 7, 2024, 10:12 PM EDT - 1 year ago

INNOVATE Corp. (VATE) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

INNOVATE Corp. Announces First Quarter 2024 Results

Apr 26, 2024, 9:05 AM EDT - 1 year ago

INNOVATE Corp. to Report First Quarter 2024 Results on May 7th

Apr 24, 2024, 4:47 PM EDT - 1 year ago

INNOVATE Corp. Announces Closing of Rights Offering

Apr 22, 2024, 8:01 AM EDT - 1 year ago

INNOVATE Corp. Announces Preliminary Results of Rights Offering

Apr 9, 2024, 4:18 PM EDT - 1 year ago

INNOVATE Corp. Announces Further Extension of Rights Offering Subscription Period

Mar 25, 2024, 4:35 PM EDT - 1 year ago

INNOVATE Corp. Announces Extension of Rights Offering Subscription Period

Mar 8, 2024, 9:00 AM EST - 1 year ago

INNOVATE Corp. Announces Commencement of Rights Offering

Mar 6, 2024, 8:00 AM EST - 1 year ago

INNOVATE Corp. Announces Rights Offering Pricing

Mar 4, 2024, 6:10 PM EST - 1 year ago

INNOVATE Corp. (VATE) Q4 2023 Earnings Call Transcript

Mar 4, 2024, 4:05 PM EST - 1 year ago

INNOVATE Corp. Announces Fourth Quarter and Full Year 2023 Results

Feb 26, 2024, 8:00 AM EST - 1 year ago

INNOVATE Corp. Announces Rights Offering for Common Stock

Feb 15, 2024, 1:09 PM EST - 2 years ago

Glancy Prongay & Murray LLP Announces Investigation of INNOVATE Corp. (VATE)

Feb 12, 2024, 4:05 PM EST - 2 years ago

INNOVATE Corp. to Report Fourth Quarter and Full Year 2023 Results on March 4th

Nov 9, 2023, 8:45 PM EST - 2 years ago

INNOVATE Corp. (VATE) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:05 PM EST - 2 years ago

INNOVATE Corp. Announces Third Quarter 2023 Results

Oct 30, 2023, 8:00 AM EDT - 2 years ago

INNOVATE Corp. to Report Third Quarter 2023 Results on November 9th

Aug 22, 2023, 9:20 AM EDT - 2 years ago

Why Chris DeMuth Jr. Likes Activision, Oil & Gas + Innovate

ATVI

Foooxx Dec. 25 at 1:06 PM

$VATE Load done, ready to go up!!

0 · Reply

Foooxx Dec. 22 at 6:39 PM

$VATE

0 · Reply

IcePhoenix Dec. 17 at 4:46 PM

$VATE undervalued

0 · Reply

Rachs88 Dec. 16 at 1:17 PM

$VATE why isn't anyone talking about this?

0 · Reply

dbr_island Dec. 16 at 1:14 PM

0 · Reply

Mapagotrades Dec. 16 at 1:06 PM

$VATE MediBeacon® Next Generation TGFR™ System Receives FDA Approval

0 · Reply

Stock_Catcher Dec. 16 at 1:05 PM

$VATE MediBeacon® Next Generation TGFR™ System Receives FDA Approval

0 · Reply

Black_Jobs Nov. 21 at 1:35 PM

$VATE why is there no price here?

0 · Reply

d_risk Nov. 12 at 10:04 PM

0 · Reply

GrindTime Nov. 6 at 3:44 PM

$VATE thats right....

0 · Reply

GrindTime Oct. 25 at 12:18 PM

$VATE

0 · Reply

GrindTime Oct. 24 at 9:01 PM

$VATE finally setup to run

1 · Reply

BigPennyStockAlerts Oct. 21 at 12:06 PM

$VATE MediBeacon receives regulatory approval to sell the Transdermal GFR System in China

0 · Reply

GrindTime Oct. 14 at 11:51 AM

$VATE Will Vate return to 75?

0 · Reply

Ezmoney2023 Sep. 10 at 12:39 PM

$VATE DBM - Critical infrastructure Spectrum - critical data/communication transfer Life Science - Critical in optimizing health American Dynamism at its finest!

0 · Reply

NVDAMillionaire Sep. 10 at 11:17 AM

$VATE Great piece that accurately captures VATE's current position. So if you want to refresh your understanding of VATE or learn about VATE for the first time, this is essential reading. https://beyondspx.com/quote/VATE/analysis/innovate-corp-unlocking-value-amidst-capital-structure-transformation-nyse-vate

0 · Reply

Grandmasim Sep. 9 at 6:16 PM

$MB $XTKG $DLTH $ICG $VATE Everyone needs tp report this clown for spamming the same garbage on hundreds of boards today.

0 · Reply

GluttonBoy Sep. 9 at 6:04 PM

TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play Watching $MB $XTKG $DLTH $ICG $VATE

1 · Reply

Scizz413 Sep. 4 at 1:29 AM

$VATE 70 mil market cap 1 billion in revenue 1.3 billion in upcoming contracts nobody is paying attention here

0 · Reply

GrindTime Aug. 22 at 11:11 AM

$VATE Needs to get above 21.5. If it can then maybe it can see 47?

1 · Reply

GrindTime Aug. 7 at 2:32 PM

$VATE time approaches...

0 · Reply

GrindTime Aug. 5 at 2:45 PM

$VATE has awoken for its wave 3. To 100 we go?

0 · Reply

Market Cap	69.50M
Revenue (ttm)	1.11B
Net Income (ttm)	-34.60M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-3.13%
Debt to Equity Ratio	-3.24

Volume	12,000
Avg Vol	32,886
Day's Range	N/A - N/A
Shares Out	13.66M
Stochastic %K	70%
Beta	1.57
Analysts	Strong Buy
Price Target	N/A